MUMBAI-based pharmaceutical giant Cipla has opened its Australian headquarters in Melbourne. Cipla is the world’s largest manufacturer of antiretroviral drugs for patients with HIV/AIDS and has a turnover of US$1.4 billion per annum and more than 20,000 employees worldwide. One of the first investments by the company in a regional office outside India, the local office was officially opened by Dr Amanda Caples, Executive Director, Science & Technology Programs on behalf of the Victorian Govt. “Through our local staff Cipla will provide superior service to existing customers, build its customer base and provide expert advice to our R&D department on requirements of the Australian medicines market for future product opportunities,” said Oskar Hakansson, Cipla Head – Australia & New Zealand. Hakansson is pictured right with Dr Caples opening the new Melbourne headquarters.
THE Pharmacy Guild of Australia’s approach to politics is “non-partisan and focused on aligning the mutual interests of its community pharmacy members with those of the government, which is tasked with representing the interests of consumers,” says Guild executive director David Quilty writing in Forefront this week.
CHANGES to Australia’s Data Breach Notification Laws which became effective last month have significant implications for Australian pharmacy businesses, according to Giuseppe Carollo from pharmacy insurance specialist Carollo Horton.